MyCartis

📍 Zwijnaarde, Belgium🗓 Founded 2014👥 3 employees💰 Last funded Apr 2016
Medical Equipment Manufacturing🌐 mycartis.net
Website LinkedIn
MyCartis is an immuno-diagnostic solution provider assuring accurate, clinical guidance with its sample to answer Evalution® platform. MyCartis develops its own immuno-diagnostic menu for the clinical user and collaborates with partners to port assays on its platform. EVALUTION® leverages high quality analytical performance from conventional immunodiagnostic approaches with the unique capability to quantify and monitor binding reactions in real-time. This provides the user with novel, timely and hence highly actionable information. MyCartis primarily focuses on oncology and in particular immuno-oncology. One of the assays in development will monitor adverse events in cancer patients undergoing immuno-oncology treatment. In addition to the existing Evalution® RUO platform, MyCartis is developing a CE-IVD clinical configuration and has obtained its ISO13485 certification. Visit www.mycartis.net or contact MyCartis for more information: info@mycartis.net
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
United Kingdom
1
Frequently asked questions
Who invested in MyCartis?
MyCartis has 2 investors on record on gritt.io, including 2 early-stage backers.
When did MyCartis last raise funding?
The most recent investment in MyCartis recorded on gritt.io was in April 2016.
When was MyCartis founded?
MyCartis was founded in 2014.
What industry is MyCartis in?
MyCartis operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is MyCartis based?
MyCartis is headquartered in Zwijnaarde, Belgium.